Endometrial hyperplasia versus carcinoma: does phosphatase and tensin homolog immunohistochemical expression differentiate between them - Egyptian Knowledge Bank - troweb

370275

Endometrial hyperplasia versus carcinoma: does phosphatase and tensin homolog immunohistochemical expression differentiate between them

Article

Last updated: 05 Jan 2025

Overview Similar Items

Article

Value of H-TERT and CD10 in differentiating endometrial carcinoma from atypical endometrial hyperplasia: an immunohistochemical study

Article

A Comprehensive Clinicopathological Analysis of Carcinoma of Endometrium: Histotype- Immunophenotype Correlation

Article

Predictors of progestin therapy response in endometrial hyperplasia: An immunohistochemical study

Article

INTERNATIONAL ENDOMETRIAL TUMOR ANALYSIS AND ITS RELATION TO ENDOMETRIAL PATHOLOGY

Article

Diagnosis of Endometrial Hyperplasia and Endometrial Cancer via Hysteroscopic Biopsy versus Dilatation and Curettage Biopsy

Article

Her-2 Neu Expression in Endometrial Carcinoma

Article

P53 EXPRESSION AS A RISK FACTOR IN TYPE 1 ENDOMETRIAL CANCER

Article

Stratification of Endometrial Carcinoma Patients Using Immunohistochemistry for Better Surgical Planning and Prognosis

Article

Correlation of Endometrial Thickness and Histopathological in Women with Post-Menopausal Bleeding

Article

Expression of Her-2/neu in endometrial carcinoma and its relation with clinicopathological variables